-- Return to Faculty Page - Kavita Shah
| Next | Last |
Records 1 to 20 of 63
| Authors | Title | Journal | Year | Vol. |
Issue | Pages |
| Johnson, E. O.;Chang, K. H.;Ghosh, S.;Venkatesh, C.;Giger, K.;Low, P. S.;Shah, K. | LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy | Journal of Cell Science | 2012 | 125 | - | 1204-1216 |
| Kumar D, Kumar NM, Ghosh S, Shah K | Novel bis(indolyl)hydrazide-hydrazones as potent anticancer agents | Bioorg Med Chem Lett | 2012 | 22 | - | 212-5 |
| Johnson EJ, Chang KH, Ghosh S, Venkatesh C, Giger K, Low PS, Shah K. | LIMK2, A Critical Regulator and Effector of Aurora A Kinase-mediated Malignancy | J Cell Science | 2012 | 125 | - | 1204-16 |
| Kumar D, Arun V, Maruthi Kumar N, Acosta G, Noel B, Shah K | A Facile Synthesis of Novel Bis-(indolyl)-1,3,4-oxadiazoles as Potent Cytotoxic Agents | ChemMedChem | 2012 | - | - | doi:10.1002/cmdc.201200363 |
| Kumar D, Kumar NM, Noel B, Shah K | A series of 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles as potent cytotoxic agents | Eur J Med Chem. | 2012 | 55 | - | 432-8 |
| Chang KH, Vincent F, Shah K. | Deregulated Cdk5 Triggers Aberrant Activation of Cell Cycle Kinases and Phosphatases Inducing Neuronal Death | J Cell Sci | 2012 | 125 | - | Aug 16. [Epub ahead of print] |
| Kumar D, Kumar NM, Chang KH, Shah K | Synthesis of Novel Indolyl-1,2,4-triazoles as Potent and Selective Anticancer Agents. | Chem Biol Drug Des. | 2011 | 77 | - | 182-8 |
| Chang KH, Multani PS, Sun KH, Vincent F, de Pablo Y, Ghosh S, Gupta R, Lee HP, Lee HG, Smith MA, Shah K | Nuclear Envelope Dispersion Triggered by Deregulated Cdk5 Precedes Neuronal Death | Mol Biol Cell | 2011 | 22 | - | 1452-1462 |
| Kumar D, Patel G, Chavers A, Chang KH, Shah K | Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents. | Eur J Med Chem | 2011 | 46(7) | - | 3085-92 |
| Sun KH, Chang KH, Clawson S, Ghosh, S, Mirzaei H, Regnier F, Shah, K | Glutathione S-transferase P1 is a Critical Regulator of Cdk5 Kinase Activity | J Neurochem | 2011 | 188 | - | 902-14 |
| Kumar D, Kumar NM, Chang KH, Gupta R, Shah K | Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles | Bioorg Med Chem Lett. | 2011 | 21(19) | - | 5897-900 |
| Kumar D, Vadulla BR, Chang KH, Shah K | One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles | Bioorg Med Chem Lett. | 2011 | 21(8) | - | 2320-3 |
| Johnson EO, Chang KH, de Pablo Y, Ghosh S, Mehta R, Badve S, Shah K. | PHLDA1 is a Crucial Negative Regulator and Effector of Aurora A Kinase in Breast Cancer | J Cell Science | 2011 | 124 | - | 2711-2722 |
| Chi X, Amet T, Byrd D, Chang KH, Shah K, Hu N, Grantham A, Hu S, Duan J, Tao F, Nicol G, Yu Q. | Direct effects of HIV-1 Tat protein on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain | Plos One | 2011 | 6(9) | - | e24412. |
| Sun, K. H.;Chang, K. H.;Clawson, S.;Ghosh, S.;Mirzaei, H.;Regnier, F.;Shah, K. | Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity | Journal of Neurochemistry | 2011 | 118 | 5 | 902-914 |
| Kumar D, Kumar M, Sundaree S, Johnson, E, Shah, K | An expeditious synthesis and anticancer activity of novel 4-(3'-indolyl)oxazoles. | Eur J Med Chem | 2010 | 45(3) | - | 1244-9 |
| Chang KH, Pablo Y, Lee H, Lee H, Smith M, Shah K | Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease. | J Neurochem | 2010 | 113(5) | - | 1221-9 |
| Kumar D, Kumar ND, Chang KH, Shah K | Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles | Eur J Med Chem | 2010 | 45(10) | - | 4664-8 |
| Kumar D, Patel G, Johnson, E, Shah, K | Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles | Bioorg Med Chem Lett | 2009 | 19(20) | - | 2739-41 |
| Sun KH, Lee HG, Smith MA, Shah K | Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease | Mol Biol Cell | 2009 | 20(21) | - | 4611-19 |
